ロード中...
Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
BACKGROUND/AIMS: Bevacizumab and ranibizumab are routinely used to treat diabetic macular edema (DME). We aim to evaluate the usefulness of switching to ranibizumab therapy following bevacizumab treatment failure in eyes with DME. METHODS: We performed a retrospective analysis of a consecutive group...
保存先:
| 出版年: | Case Rep Ophthalmol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357677/ https://ncbi.nlm.nih.gov/pubmed/25802504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000375230 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|